|
Indian Pediatr 2015;52: 249-250 |
 |
Infantile Tremor Syndrome – Down but not Out
|
*Jatinder S Goraya and
#Sukhjot Kaur
*Division of Pediatric Neurology, Department of
Pediatrics; and #Department of Dermatology; Dayanand Medical College and
Hospital, Ludhiana, Punjab,India.
Email: [email protected]
|
Retrospective chart review of 21 infants with infantile tremor syndrome
for vitamin B12 deficiency showed low serum vitamin B12 levels in 8/16
(50%). Of the eight infants with normal levels, six had received vitamin
B12 before referral. Macrocytosis and low maternal serum B12 was found
in 12 and seven cases each. Treatment with vitamin B12 alone produced
rapid recovery.
Keywords: Movement disorder, Vitamin B12
|
Infantile tremor syndrome (ITS) is characterized by pallor,
developmental regression, tremors, hyperpigmentation of skin, and sparse
brown hair. [1]. Though considered to be a vitamin B 12
deficiency state by many, opinion has remained divided. We describe some
children with ITS to highlight its continued occurrence and also report
on its probable etiology.
A retrospective review of the medical records of the
children with infantile tremor syndrome attending our center between
February 2010 and August 2014 was done. We investigate all infants with
ITS and their mothers for vitamin B 12
deficiency. All infants are initially treated with intramuscular vitamin
B12 alone.
Twenty-one infants, (13 boys) aged 6 to 27 month were
studied. Common presenting symptoms were tremors in 12, developmental
delay in three, and developmental regression in three. All infants were
exclusively breast-fed and their mothers were vegetarians, with little
or no milk intake. We found low serum B 12
in 8 of the 16 infants. Six of the 8 infants with normal serum vitamin B12
had received vitamin B12
before referral. Clinical and laboratory parameters are summarized in
Table I. After treatment with intramuscular vitamin B12
alone, improvement in general activity, interest in surroundings, and
return of social smile was seen within 48-72 hours in all except one.
Tremors started to diminish by the end of first week in eight infants.
Six infants showed initial worsening of tremors following treatment.
Tremors were completely resolved by three to four weeks in all.
TABLE I Clinical and Laboratory Findings in Infants With Infantile Tremor Syndrome
Clinical findings (n=21) |
Number (%) |
Developmental delay and/or regression |
21(100) |
Brown scanty hair |
21(100) |
Skin hyperpigmentation |
21(100) |
Pallor |
21(100) |
Lethargy/apathy |
21(100) |
Growth retardation* |
16(78) |
Hypotonia |
15(75) |
Tremors |
14(73) |
Laboratory findings (n=18) |
Number(%) |
Anemia (haemoglobin d” 11g/dl) |
15(83.3) |
Macrocytosis (MCV>95) |
12(66.6) |
**Low serum B12 (n=16) |
8(50) |
Low maternal serum B12 |
7(100) |
Diffuse cerebral atrophy on neuroimaging |
7(100) |
*2 infants each also had glossitis, angular cheilitis, edema,
and rickets; **of the 8 infants with normal serum vitamin B12, 6
had received vitamin B12 before referrals. |
There is epidemiological, clinical, laboratory and
therapeutic evidence to suggest that vitamin B12
deficiency is causally associated with ITS [2-4]. Epidemiologically, ITS
occurs in exclusively breastfed infants of mothers living on diet devoid
of animal products, including milk, pointing to vitamin B12
deficiency in infant-mother pairs [3]. All the mothers tested in our
series had low serum vitamin B12.
Moreover, the manifestations of ITS are identical to those described
with infantile vitamin B12
deficiency reported from West [4]. Skin hyperpigmentation seen in ITS is
also a well-known sign of vitamin B12
deficiency [5]. Infants with normal serum vitamin B12
levels
in this study had other evidence of vitamin B12
deficiency such as macrocytosis and low maternal serum vitamin B12.
From therapeutic standpoint, unequivocal improvement in general activity
was observed in all the treated infants within 48-72 hours of vitamin B12.
Tremors also improved gradually, all although initial worsening of
tremors, a well-documented feature of vitamin B12
deficiency [6], was encountered in six infants
Interestingly enough, first study on ITS by Dikshit
[1] had provided initial evidence that the symptoms and signs could be
due to vitamin B 12
deficiency. Later authors also reported low serum vitamin B12
and good response to vitamin B12
[2,3]. Deshpande and Ingle [7] also concurred with
vitamin B12 deficiency in
ITS. Elegant study by Garewal, et al. [8] showed unambiguous
evidence of vitamin B12
deficiency in ITS in the form of megaloblastic bone marrow, and low
serum vitamin B12, including
cellular evidence of vitamin B12
deficiency was revealed by the dU suppression test. On the other hand,
in the studies showing lack of evidence of vitamin B12
deficiency in ITS, serum vitamin B12,
the current gold standard of diagnosis of vitamin B12
deficiency, was not measured and results were inferred from the mere
absence of peripheral blood macrocytosis and megaloblastic bone marrow
[9,10]. Occurrence of neurological symptoms of vitamin B12
deficiency in the absence of concomitant hematological changes is well
known [8,11]. Interestingly, publication bias also seems to have played
a major role in this debate on etiology of ITS. Majority of the studies
[2,3,8] reporting vitamin B12
deficiency in ITS were published in foreign journals and likely to have
escaped scrutiny of researchers of the country.
In summary, ITS continues to exist in India in modern
times and is causally associated with vitamin B 12
deficiency. Since long-term neuro-developmental deficits can occur if
treatment is delayed, infants with ITS should be treated early with
vitamin B12 for rapid
reversal of neurological signs.
Contributors: JSG: conceptualized the study,
collected the data and wrote the initial and final draft; SK:
participated in the data analysis, performed the literature review, and
revised the manuscript.
Funding: None; Competing interest: None
stated.
References
1. Dikshit AK. Nutritional dystrophy with anemia.
Indian J Child Hlth. 1957;6:132-6.
2. Jadhav M, Webb JKG, Vaishnava S, Baker SJ. Vitamin
B12 deficiency in Indian infants. Lancet. 1962;1:903-90.
3. Srikantia SG, Reddy V. Megaloblastic anemia of
infancy and vitamin B12. Br J Hematol. 1967;13:949-53.
4. Dror DK, Allen LH. Effect of vitamin B12
deficiency on neurodevelopment in infants: current knowledge and
possible mechanisms. Nutrition Reviews. 2008;66:250-5.
5. Simsek OP, Gonc N, Gumruk F, Cetin M. A child with
vitamin B12 deficiency presenting with pancytopenia and
hyperpigmentation. J Pediatr Hematol Oncol. 2004;26:834-6.
6. Gratten-Smith PJ, Wilcken B, Procopis PG. The
neurological syndrome of infantile cobalamin deficiency: Developmental
regression and involuntary movements. Mov Dis. 1997;12:39-46.
7. Deshpande TV, Ingle VN. Tremor syndrome in
children. Indian Pediatr. 1969;6:550-6.
8. Garewal G, Narang A, Das KC. Infantile tremor
syndrome: A vitamin B12 deficiency syndrome in infants. J Trop Pediatr.
1988;34:174-8.
9. Pohowalla JN, Kaul KK, Bandari NR, Singh SD.
Infantile "meningo-encephalitic’’ syndrome. Indian J Pediatr.
1960;27:49-54.
10. Sachdev KK, Manchanda SS, Lal H. The syndrome of
tremors, mental regression and anemia in infants and young children. A
study of 102 cases. Indian Pediatr. 1965;2:239-51.
11. Rasmussen SA, Fernhof PM, Scanlon KS. Vitamin B12 deficiency in
children and adolescents. J Pediatr. 2001;138:10-7.
|
|
 |
|